Skip to content

Drug interactions

Nirmatrelvir + Sofosbuvir-velpatasvir

Severity: Minor

Nirmatrelvir and Sofosbuvir-velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nirmatrelvir, given with ritonavir, inhibits CYP3A4 and P-gp, which may raise velpatasvir and sofosbuvir levels. The increase is unlikely to be harmful over a short 5-day course.

What this interaction means in plain words

Nirmatrelvir and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Nirmatrelvir belongs to Anti Virals; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Ritonavir-boosted nirmatrelvir inhibits CYP3A4 and P-gp, reducing clearance of velpatasvir and sofosbuvir.

What to do

No dose change is required. Monitor for general adverse effects during the short course.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nirmatrelvir and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nirmatrelvir with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as minor. Nirmatrelvir and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nirmatrelvir, given with ritonavir, inhibits CYP3A4 and P-gp, which may raise velpatasvir and sofosbuvir levels. The increase is unlikely to be harmful over a short 5-day course.

How serious is the interaction between Nirmatrelvir and Sofosbuvir-velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required. Monitor for general adverse effects during the short course.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in